Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2011-11-15
Original SEC Filing: Click here

---

Webplus: SKBI/20111115/8-K_1/2_EX-99.1/000.htm SEC Original: v240684_ex99-1.htm
LOGO NEWS RELEASE Skystar Bio-Pharmaceutical Announces Revenue of $20.9 Million For Third Quarter Fiscal Year 2011 Revenues up 12.6%; Net Income up 16.2%; EPS of $1.08 Per Basic and Fully Diluted Share XI’AN, CHINA – November 14, 2011 — – Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) (“Skystar” or the “Company”), Third Quarter 2011 Highlights · Revenue increases 13% YoY to record $20.9

---

---

Webplus: SKBI/20111115/8-K_1/1/000.htm SEC Original: v240684_8k.htm
FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): November 15, 2011 (November 14, 2011) SKYSTAR BIO-PHARMACEUTICAL COMPANY Nevada 001-34394 33-0901534 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employer Identification No.) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District, Xi’an, Shaanxi Province, P.R. China (8629) 8819-3188 (Issuer Telephone Number)

---

Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2011-11-15CIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4, FENGHUI ROAD SOUTH, GAOXIN DISTRICT
XIAN PROVINCE